RxDoctor Payments Data

Christine Mumey, NP

Nurse Practitioner · Salem, ORNPI 1295234300

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.5% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 47 manufacturers, the largest accounting for just 8.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,359, 3.0 times the $447 reported in 2021. Among nurse practitioner clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,189in general payments, 2019–2025

Across 158 payments — averaging $26.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$358
  • E.r. Squibb & Sons, L.L.C.$319
  • Pfizer$317
  • AstraZeneca$275
  • Merck$229
  • Seagen Inc.$169
  • plus $3K from 41 others

What the payments were for

  • Food & beverage$4,08598%
  • Education$1042%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,189 in reported general payments places this provider in the 95th percentile of 997 nurse practitioner providers in Oregon.

See all nurse practitioner providers in Oregon

Medicare billing

Part B allowed, 2024
$31,640
Medicare patients
102
Services billed
914

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron Hcl15$179
Prochlorperazine Maleate18$145
Anastrozole11$86

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Salem

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →